We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/3/2018 13:58 | Yep and there is also some foreground selling activity as well, nothing to get excited about though really I would have thought going on past experience. Nearly 4 months have elapsed since Colin King spouted 'As noted in our interim results announcement last week, we remain positive that we will conclude commercialisation discussions with Immunodiagnostic Systems in the near future.", this just typifies the ODX board up perfectly, the silence is deafening which is pathetic really bearing in mind discussions were first muted way back in November 2016. However I constantly remind myself that I should remain optimistic despite the numerous disappointments I have witnessed during the past 6 years as a long suffering ODX shareholder! 😇 | hyperboreus | |
08/3/2018 12:24 | Yep! And there's a 60k late reported buy which explains today's rise. | rivaldo | |
08/3/2018 11:32 | Background demand??? 🤔 | hyperboreus | |
08/3/2018 11:24 | Good to see a series of small upward moves, with another today. Looks like some background demand here. | rivaldo | |
03/3/2018 22:07 | Well I wish you a smooth move barry. I expect the weather won't be a problem by Tuesday, outside of the last vestiges of slush and some flood potential in various locales. Been ok here. I'm in Edinburgh from early Monday next week & it has been on red weather warning but I don't expect it will remain that way long even there. | p1nkfish | |
03/3/2018 10:39 | You are right p1nkfish IDH performance is dire their share price is dropping even though the only ones buying their shares are them on their share buyback scheme. If the IDH deal doesn't go through I hope ODX can find another partner quickly... I hope every one is safe after the bad weather, I am moving house on Tuesday weather permitting....... | barrywhit | |
03/3/2018 00:18 | IDH do need a rocket. Their performance is dire. What chance they might make a cheeky bid so ODX offer them some growth as a bolt-on? | p1nkfish | |
02/3/2018 23:13 | Take his posts with a pinch of salt... | barrywhit | |
28/2/2018 23:36 | Given the number of days waited we have to hope any deal compensates for the time spent. | p1nkfish | |
28/2/2018 19:14 | Lets hope the new CEO improves news flow, with regards IDH Deal I have already voiced my concerns with the time taken and their reply was, we are working on a daily basis to try and put a deal together. Lets hope they can put a deal together.... | barrywhit | |
28/2/2018 18:33 | Yes, can agree barry but it's the way they have "unmanaged" the share price for years and I don't see it changing. We know the way it is so as blunt as it sounds people will sell down to the point buyers see value and join. IDH, a mystery. Getting to a point where have to suspect all is not good. | p1nkfish | |
28/2/2018 17:49 | On the idh deal this has taken far too long for any normal deal makes me wonder if idh are still looking to buy that side of the business? As no directors have taken advantage of the drop in price! | leedslad001 | |
28/2/2018 08:46 | The trouble with that p1nkfish is their major investors will finally get fed up waiting for good news, we have lost at least one large investor going by the selling over the last 3 to 4 months, they need to attract a couple of new serious investors, the IDH deal is obviously struggling to happen they have been talking for about 15 months.... | barrywhit | |
27/2/2018 23:49 | The only reason I think they will support the share price specifically is if they want to use issuance for acquisition(s) otherwise its down to natural ebb and flow.. | p1nkfish | |
27/2/2018 20:54 | Averaging down, will see whether I can pick more tomorrow. Management not doing enough to support price though. | jeevsje | |
27/2/2018 19:55 | Well done Jeevsje.. | barrywhit | |
27/2/2018 15:40 | Someone picking up shares at 16p today.....Sneller?? | barrywhit | |
13/2/2018 09:52 | todays sell only purchased on the 8th Feb. another loss for a trader.... | barrywhit | |
09/2/2018 22:04 | Never mind Barry. Back to 2015 most likely then. | p1nkfish | |
09/2/2018 13:33 | 16p obviously wasn't the bottom p1nkfish.. | barrywhit | |
07/2/2018 08:07 | Medtech link below worth a read as ODX line-up with FDA strategy. ODX - "a digital health strategy is being developed in conjunction with the North American distribution partners for the food intolerance products, to assist both users of the tests and their medical advisers make better informed decisions based on the outcome of the tests. North America is a new market being tackled and once this digital solution is developed, it will be able to be used in other regions." FDA - | p1nkfish | |
07/2/2018 07:58 | Good point p1nkfish.It is easy to lose sight of just how diversified this business is but coupled with plenty of short/medium term developments that will, in due course, start delivering enhanced returns. | longshanks | |
06/2/2018 21:41 | Hygeas' take from their results. I forgot about the US digital health strategy. "re the CD4 potentially transformational project (which started in 2012), the achievement of CE marking was announced in November 2017. This is expected to result in modest sales during 2018, whilst additional regulatory approval is sought through the World Health Organisation Prequalification programme. Achievement of the latter is expected to result in significant sales being achieved thereafter; re the IDS-iSYS potentially transformational project (which started in 2013), CE marking of a menu of 49 allergens has been achieved, with a further 9 due to be added over the next few months. Commercialisation discussions with AIM listed Immunodiagnostic Systems Holdings plc, the owner of the IDS-iSYS platform, are expected to be concluded in the near future; the malaria assay referred to in last year's Annual Report has been launched and is in the process of being commercialised; and a digital health strategy is being developed in conjunction with the North American distribution partners for the food intolerance products, to assist both users of the tests and their medical advisers make better informed decisions based on the outcome of the tests. North America is a new market being tackled and once this digital solution is developed, it will be able to be used in other regions." | p1nkfish | |
06/2/2018 21:22 | Double checked my thinking - it is a push but not beyond possible. They do need a beefier list of institutional holders. About 51M shares outside the 3% holders, approx 40% of shares in issue. Given the recent shake the volumes changing hands has been ridiculously low knowing 40% are outside 3%'ers. | p1nkfish |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions